31 Mean pain intensity score, evaluated using the modified short-form MPQ, was significantly lowered during the study, whereas electrophysiological parameters did not show significant changes
Cardiovascular events add substantially more
Report signs of infection at injection sites, systemic allergic reactions, or unexpected swelling beyond localized redness
This is why close monitoring and possible medication adjustment by your provider is essential if you initiate GLP-1 therapy while taking blood pressure drugs
Indications: FDA : Resistant Hypertension 2025 Clinical Guidelines Reserpine remains an FDA-approved drug for the treatment of hypertension
The improvement in endothelial function might be attributed to an increase in bacteria capable of producing nitric oxide, as it helps dilate blood vessels and improve blood flow, ultimately benefiting cardiovascular health